OMDANasdaqServices-Health ServicesFiscal year ends December 31

Omada Health, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026

$18.06+0.43 (+2.44%)

Close on Oct 19, 2026

Market cap: $1.15B
P/E (TTM): –
Dividend yield: –

Omada Health, Inc. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31
Revenue	260	170	123
Cost of Revenue	89	67	53
Gross Profit	171	103	70
Research & Development	41	36	34
Selling, General & Admin	142	111	102
Selling & Marketing	90	68	66
General & Administrative	52	43	36
Advertising Expenses	0.60	0.50	0.80
Operating Expenses	183	147	136
Operating Income	-12	-44	-66
Interest Expense	2.53	4.51	4.71
Interest & Investment Income	5.31	0.81	5.78
Other Non-Operating Income	-0.81	-3.48	-1.51
Asset Impairment Charges	0	0	0
Gain (Loss) on Sale of Assets	-0.01	0.00	-0.15
Pretax Income	-13	-47	-68
Income Tax Expense	0	0	0
Net Income	-13	-47	-68
EPS (Basic)(per share)	-0.35	-6.11	-9.52
EPS (Diluted)(per share)	-0.35	-6.11	-9.52
Shares Outstanding (Basic, Weighted)(shares)	37	7.72	7.09
Shares Outstanding (Diluted, Weighted)(shares)	37	7.72	7.09
EBITDA	-6.48	-39	-62

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 68.2%
Operating margin: -0.1%
Net margin: 1.4%
Return on equity, FY2025: 16.5%

Financial strength

Current ratio: 3.91
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 293.7%

Valuation

P/E ratio: –
Price to sales: 3.73
Price to book: 4.57
Dividend yield: –